PTEN and colorectal carcinoma: Given diverse mechanisms that lead to PTEN inhibition in CRC, several strategies aiming to restore oncosuppressor functions have been hypothesized and are currently under evaluation in the early phases of preclinical research (Figure 2; Table 2) [56].